Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Just One Number Will Convince You Not to Buy Zoom Stock

It's okay to like the company, but if traditional valuation metrics mean anything anymore, then you might want to avoid ZM stock for now.

Frothy Valuation and Red Flags Mean Avoid Plug Power Stock at Today’s Prices

In short, "priced for perfection," with factors at play that could sink shares back to prior levels, today's share price ($13 per share) is not a great entry point for PLUG stock.

There’s No Real Value Left in Whiting Petroleum Stock

Sadly, a once mighty oil company is now going bankrupt. Knowing this, there's no need to gamble on fast-falling WLL stock.

There Are Still 1.6 Million Reasons You’re Wrong About Luckin Stock

Despite its ongoing legal issues, Luckin stock still gets interest from speculative investors. But a flawed business model begs the question why?

Virgin Galactic Is Appealing to the Wrong Generation

SPCE stock may sound appealing at first glance but the finer details suggest that it’s less relevant to current investors than you might think.

iBio Is an Afterthought in the Covid-19 Vaccine Race

IBIO stock is a speculative play due to the slow development of its pipeline and its lack of much support from external parties.

With Buffett Selling Occidental Stock, Other Investors Probably Will Follow

OXY stock has been through a lot this year. But until the price of oil picks up, there's still more pain ahead.

Under Armour Is Waking Up Far Too Late

When its rivals were taking a difficult stance for justice, Under Armour was busy being toxic. Now, that decision will come to haunt UA stock.

Taoping Isn’t the Chinese Stock to Embrace

Taoping stock is a mess and things could get worse because the company isn't really capturing much of China's growing cloud market.

Marathon Patent Stock Is Not the Cryptocurrency Play You Might Think It Is

Traders have bid up MARA stock as cryptos soar again. However, Marathon's crypto-mining business is nowhere near profitability yet.

Exxon Mobil Stock’s 8.7% Dividend Yield Reeks of Desperation

Exxon Mobil’s dividend is currently yielding 8.7%. Does that make Exxon Mobil stock a buy? No, but not for the reason you might think.

It’s Best to Avoid Ocugen Stock at the Moment

Until we begin to see solid trial results, OCGN stock could easily plunge back to 20 cents a share. Avoid investing in Ocugen for now.

It Makes No Sense to Buy Chesapeake Energy Shares

There’s also no certainty of survival down the road for Chesapeake Energy stock – at least, not near term. Stay far away from the stock.

3 Gold Stocks That Are Quickly Losing Their Luster

Gold stocks have been on a tear of late, but not all stocks in the space have done well. Here are three that have struggled.

Steer Clear of Coronavirus Vaccine Also-Ran iBio Stock

So, what's the play here? Too risky to go long (or short), stay far away vaccine play IBIO stock. Other vaccine candidates may offer opportunity. But, this "also-ran" isn't much of a contender.

Chesapeake Energy Stock Has No Real Hope for a Comeback

Chesapeake was staggered by the pandemic and an oil price war, and after bankruptcy Chesapeake Energy stock is a risky bet.

Whiting Will Exit Bankruptcy, But That Won’t Save Investors

Whiting is set to leave bankruptcy over the next week. But don't count on a comeback for WLL stock, as shares will be nearly wiped out in the reorganization.

Buffett’s Sale of 100% of His Occidental Common Stock Is All Investors Need to Know

Warren Buffett sold all of his Occidental Petroleum common stock in the second quarter. OXY stock appears to be a hopeless cause.

Without a Partner, iBio’s Gains Are Just a Fantasy

iBio is behind others in developing a Covid-19 vaccine and it doesn't have a FastPharming partner. There's diminishing value to IBIO stock.